These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9718275)

  • 21. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.
    Wagenknecht B; Gulbins E; Lang F; Dichgans J; Weller M
    FEBS Lett; 1997 Jun; 409(1):17-23. PubMed ID: 9199495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).
    Gonçalves A; Braguer D; Carles G; André N; Prevôt C; Briand C
    Biochem Pharmacol; 2000 Dec; 60(11):1579-84. PubMed ID: 11077039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells.
    Saito R; Mizuno M; Hatano M; Kumabe T; Yoshimoto T; Yoshida J
    J Neurooncol; 2004 May; 67(3):273-80. PubMed ID: 15164982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
    Streffer JR; Schuster M; Pohl U; Belka C; Dichgans J; Bamberg M; Weller M
    Anticancer Res; 1999; 19(6B):5265-9. PubMed ID: 10697547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells.
    Tseng SH; Wang CH; Lin SM; Chen CK; Huang HY; Chen Y
    J Cancer Res Clin Oncol; 2004 May; 130(5):285-93. PubMed ID: 14997384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.
    Fulda S; Scaffidi C; Pietsch T; Krammer PH; Peter ME; Debatin KM
    Cell Death Differ; 1998 Oct; 5(10):884-93. PubMed ID: 10203687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release.
    Glaser T; Weller M
    Biochem Biophys Res Commun; 2001 Feb; 281(2):322-7. PubMed ID: 11181049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis.
    Posovszky C; Friesen C; Herr I; Debatin KM
    Leukemia; 1999 Mar; 13(3):400-9. PubMed ID: 10086731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
    Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
    Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrazolium violet induces apoptosis via caspases-8, -9 activation and Fas/FasL up-regulation in rat C6 glioma cells.
    Cai CF; Feng L; Wang L; Kong QZ; Zhao YF
    Arch Pharm Res; 2009 Apr; 32(4):575-81. PubMed ID: 19407976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line.
    Shain KH; Landowski TH; Buyuksal I; Cantor AB; Dalton WS
    Leukemia; 2000 May; 14(5):830-40. PubMed ID: 10803514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
    Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
    Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.
    Dörrie J; Gerauer H; Wachter Y; Zunino SJ
    Cancer Res; 2001 Jun; 61(12):4731-9. PubMed ID: 11406544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.